Nlrp3 (Nlr Family Pyrin Domain Containing 3) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
{{#vardefine:wikiId|}}
| Protein Name | NLRP3 |
|---|---|
| Gene Symbol | [NLRP3](/genes/nlrp3) |
| UniProt ID | Q9NPF4 |
| PDB Structures | 4KXF, 6N8P, 7AL0 |
| Molecular Weight | ~118 kDa |
| Subcellular Localization | Cytoplasm, inflammasome complex |
| Protein Family | NOD-like receptor family |
| Aliases | NLRP3, CIAS1, PYPAF1, NALP3, Cryopyrin |
NLRP3 (NLR Family Pyrin Domain Containing 3) is a pattern recognition receptor that forms the NLRP3 inflammasome, a multi-protein complex that activates caspase-1 and triggers the release of pro-inflammatory cytokines IL-1β and IL-18. The NLRP3 inflammasome is a central driver of neuroinflammation in Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
NLRP3 contains three functional domains:
The NLRP3 inflammasome complex includes:
In the healthy nervous system, NLRP3:
Under normal conditions, NLRP3 expression is low and tightly controlled by negative regulators.
NLRP3 contributes to AD pathogenesis through:
In PD, NLRP3 mediates:
NLRP3 inflammasome activation follows a two-step priming and activation model:
NLRP3 inflammasome inhibitors are actively being developed:
| Strategy | Compound | Status | Notes |
|---|---|---|---|
| NLRP3 inhibitors | MCC950 | Preclinical/Phase I | Direct NLRP3 ATPase inhibition |
| Dapansutrile (OLT1177) | Phase II | β-sulfonyl nitrile compound | |
| Tranilast | Approved (allergy) | Repurposed for NLRP3 | |
| IL-1β targeting | Anakinra, Canakinumab | Approved | IL-1 receptor antagonist |
| ASC inhibition | Small molecules | Research | Block inflammasome assembly |
| Caspase-1 inhibitors | VX-765 | Clinical trials | Prevent cytokine activation |
NLRP3-related biomarkers under investigation:
Nlrp3 (Nlr Family Pyrin Domain Containing 3) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Nlrp3 (Nlr Family Pyrin Domain Containing 3) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The following resources from the Allen Brain Atlas provide expression and connectivity data for this protein/gene: